Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity

Drug and Alcohol Dependence

Volumn 114, Issue 2-3, 2011, Pages 194-200

  Vassileva, Jasmin ^a   Georgiev, Stefan ^b   Martin, Eileen ^a   Gonzalez, Raul ^a   Segala, Laura ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Behavioral inhibition; Decision making; Delay discounting; Heroin addiction; Impulsivity; Psychopathy

Indexed keywords

ADULT; ARTICLE; BULGARIA; COGNITIVE DEFECT; CONTROLLED STUDY; DELAYED REWARDS DISCOUNTING TASK; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; HARE PSYCHOPATHY CHECKLIST REVISED; HEROIN DEPENDENCE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PASSIVE AVOIDANCE LEARNING TASK; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPATHY;

ADOLESCENT; ADULT; ANTISOCIAL PERSONALITY DISORDER; AVOIDANCE LEARNING; DIAGNOSIS, DUAL (PSYCHIATRY); HEROIN DEPENDENCE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 79952701337     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.09.021     Document Type: Article

References (78)

1. Ainslie G.W. Specious reward: a behavioral theory of impulsiveness and impulsive control. Psychol. Bull. 1975, 82:463-496.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1952, 1st ed. (DSM-I).
3. American Psychiatric Association Antisocial Personality Disorder. American Psychiatric Association DSM-5 Development 2010, http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid = 16, 3-17-2010.
4. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
5. Bechara A., Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002, 40:1675-1689.
6. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
7. Bechara A., Dolan S., Denburg N., Hindes A., Anderson S.W., Nathan P.E. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001, 39:376-389.
8. Bechara A., Tranel D., Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000, 123(Pt 11):2189-2202.
9. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J. Pers. Assess. 1996, 67:588-597.
10. Bickel W.K., Marsch L.A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001, 96:73-86.
11. Blair R.J., Colledge E., Mitchell D.G. Somatic markers and response reversal: is there orbitofrontal cortex dysfunction in boys with psychopathic tendencies?. J. Abnorm. Child Psychol. 2001, 29:499-511.
12. Blair R.J., Mitchell D.G., Leonard A., Budhani S., Peschardt K.S., Newman C. Passive avoidance learning in individuals with psychopathy: modulation by reward but not by punishment. Pers. Individ. Diff. 2004, 37:1179-1192.
13. Bornovalova M.A., Daughters S.B., Hernandez G.D., Richards J.B., Lejuez C.W. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Exp. Clin. Psychopharmacol. 2005, 13:311-318.
14. Brand M., Fujiwara E., Borsutzky S., Kalbe E., Kessler J., Markowitsch H.J. Decision-making deficits of Korsakoff patients in a new gambling taks with explicit rules: associations with executive functions. Neuropsychology 2005, 19:267-277.
15. Brand M., Roth-Bauer M., Driessen M., Markowitsch H.J. Executive functions and risky decision-making in patients with opiate dependence. Drug Alcohol Depend. 2008, 97:64-72.
16. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Benning S.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Cole D., Kessler R.M., Zald D.H. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat. Neurosci. 2010, 13:419-421.
17. Cooke D.J., Michie C. Psychopathy across cultures: North America and Scotland compared. J. Abnorm. Psychol. 1999, 108:58-68.
18. Cooke D.J., Michie C., Hart S.D., Clark D. Assessing psychopathy in the UK: concerns about cross-cultural generalisability. Br. J. Psychiatry 2005, 186:335-341.
19. Darke S., Kaye S., Finlay-Jones R. Antisocial personality disorder, psychopathy and injecting heroin use. Drug Alcohol Depend. 1998, 52:63-69.
20. de Wit H., Richards J.B. Dual determinants of drug use in humans: reward and impulsivity. Nebr. Symp. Motiv. 2004, 50:19-55.
21. Dolan M., Park I. The neuropsychology of antisocial personality disorder. Psychol. Med. 2002, 32:417-427.
22. Dougherty D.M., Bjork J.M., Harper R.A., Marsh D.M., Moeller F.G., Mathias C.W., Swann A.C. Behavioral impulsivity paradigms: a comparison in hospitalized adolescents with disruptive behavior disorders. J. Child Psychol. Psychiatry 2003, 44:1145-1157.
23. Evenden J.L. Varieties of impulsivity. Psychopharmacology. (Berl) 1999, 146:348-361.
24. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured clinical interview for DSM-IV axis-I disorders. Biometrics Res. Dep. 1996.
25. Fishbein D.H., Krupitsky E., Flannery B.A., Langevin D.J., Bobashev G., Verbitskaya E., Augustine C.B., Bolla K.I., Zvartau E., Schech B., Egorova V., Bushara N., Tsoy M. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend. 2007, 90:25-38.
26. Flor H., Birbaumer N., Hermann C., Ziegler S., Patrick C.J. Aversive Pavlovian conditioning in psychopaths: peripheral and central processes. Psychophysiology 2002, 39:505-518.
27. Gerstley L.J., Alterman A.I., McLellan A.T., Woody G.E. Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis?. Am. J. Psychiatry 1990, 147:173-178.
28. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
29. Hare R.D. Manual for the Hare Psychopathy Checklist - Revised 1991, Multi-Health Systems, Toronto, Ontario, Canada.
30. Hare R.D., Neumann C.S. Psychopathy: assessment and forensic implications. Can. J. Psychiatry 2009, 54:791-802.
31. Ishikawa S.S., Raine A., Lencz T., Bihrle S., LaCasse L. Autonomic stress reactivity and executive functions in successful and unsuccessful criminal psychopaths from the community. J. Abnorm. Psychol. 2001, 110:423-432.
32. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 146:373-390.
33. Kirby K.N. Bidding on the future: evidence against normative discounting of delayed rewards. J. Exp. Psychol. Gen. 1997, 126:54-70.
34. Kirby K.N. One-year temporal stability of delay-discount rates. Psychon. Bull. Rev. 2009, 16:457-462.
35. Kirby K.N., Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004, 99:461-471.
36. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 1999, 128:78-87.
37. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
38. Kosson D.S., Smith S.S., Newman J.P. Evaluating the construct validity of psychopathy in black and white male inmates: three preliminary studies. J. Abnorm. Psychol. 1990, 99:250-259.
39. Lejuez C.W., Simmons B.L., Aklin W.M., Daughters S.B., Dvir S. Risk-taking propensity and risky sexual behavior of individuals in residential substance use treatment. Addict. Behav. 2004, 29:1643-1647.
40. Losel F., Schmucker M. Psychopathy, risk taking, and attention: a differentiated test of the somatic marker hypothesis. J. Abnorm. Psychol. 2004, 113:522-529.
41. Madden G.J., Petry N.M., Badger G.J., Bickel W.K. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp. Clin. Psychopharmacol. 1997, 5:256-262.
42. Mazur J. An adjusting procedure for delayed reinforcement. The effect of delay and of intervening events on reinforcement value 1987, 55-73. Erlbaum, New Jersey. M. Commons, J. Mazur, J. Nevin, H. Rachlin (Eds.).
43. McDermott P.A., Alterman A.I., Cacciola J.S., Rutherford M.J., Newman J.P., Mulholland E.M. Generality of psychopathy checklist-revised factors over prisoners and substance-dependent patients. J. Consult. Clin. Psychol. 2000, 68:181-186.
44. Mintzer M.Z., Stitzer M.L. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002, 67:41-51.
45. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. Am. J. Psychiatry 2001, 158:1783-1793.
46. Newman J.P., Kosson D.S. Passive avoidance learning in psychopathic and nonpsychopathic offenders. J. Abnorm. Psychol. 1986, 95:252-256.
47. Newman J.P., Schmitt W.A. Passive avoidance in psychopathic offenders: a replication and extension. J. Abnorm. Psychol. 1998, 107:527-532.
48. Newman J.P., Widom C.S., Nathan S. Passive avoidance in syndromes of disinhibition: psychopathy and extraversion. J. Perspect. Soc. Psychol. 1985, 48:1316-1327.
49. Nigg J.T. Is ADHD a disinhibitory disorder?. Psychol. Bull. 2001, 127:571-598.
50. Odum A.L., Madden G.J., Badger G.J., Bickel W.K. Needle sharing in opioid-dependent outpatients: psychological processes underlying risk. Drug Alcohol Depend. 2000, 60:259-266.
51. Passetti F., Clark L., Mehta M.A., Joyce E., King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008, 94:82-91.
52. Petry N.M. Discounting of money, health, and freedom in substance abusers and controls. Drug Alcohol Depend. 2003, 71:133-141.
53. Raine A. Evoked potentials and psychopathy. Int. J. Psychophysiol. 1989, 8:1-16.
54. Raine A. Schizotypical and borderline features in psychopathic criminals. Pers. Individ. Diff. 1992, 13:717-722.
55. Raine A., Dunkin J. The genetic and psychophysiological basis of antisocial behavior: implications for counseling and therapy. J. Couns. Dev. 1990, 68:637-644.
56. Raine A., Ishikawa S.S., Arce E., Lencz T., Knuth K.H., Bihrle S., LaCasse L., Colletti P. Hippocampal structural asymmetry in unsuccessful psychopaths. Biol. Psychiatry 2004, 55:185-191.
57. Raine A., Lencz T., Taylor K., Hellige J.B., Bihrle S., LaCasse L., Lee M., Ishikawa S., Colletti P. Corpus callosum abnormalities in psychopathic antisocial individuals. Arch. Gen. Psychiatry 2003, 60:1134-1142.
58. Raine A., Venables P.H. Enhanced P3 evoked potentials during a continuous performance task in psychopaths. Psychophysiology 1988, 25:30-38.
59. Reardon M.L., Lang A.R., Patrick C.J. An evaluation of relations among antisocial behavior, psychopathic traits, and alcohol problems in incarcerated men. Alcohol Clin. Exp. Res. 2002, 26:1188-1197.
60. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 1990, 264:2511-2518.
61. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav. Pharmacol. 2006, 17:651-667.
62. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F., Sahakian B.J., Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999, 20:322-339.
63. Rutherford M., Cacciola J.S., Alterman A.I., McKay J.R., Cook T.G. The 2-year test-retest reliability of the psychopathy checklist-revised in methadone patients. Assessment 1999, 6:285-292.
64. Scerbo A., Raine A., O'Brien M., Chan C.J., Rhee C., Smiley N. Reward dominance and passive avoidance learning in adolescent psychopaths. J. Abnorm. Child Psychol. 1990, 18:451-463.
65. Schmauk F.G. Punishment, arousal, and avoidance learning in sociopaths. J. Abnorm. Psychol. 1970, 76:325-335.
66. Schmitt W.A., Brinkley C.A., Newman J.P. Testing Damasio's somatic marker hypothesis with psychopathic individuals: risk takers or risk averse?. J. Abnorm. Psychol. 1999, 108:538-543.
67. Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., 1970. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA.
68. United Nations Office on Drugs and Crime. UNODC World Drug Report 2008. 2008. http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf.
69. United Nations Programme on HIV/AIDS. (2010) UNAIDS Bulgaria 2010 Progress Report. Accessed on 09-17-2010. http://data.unaids.org/pub/Report/2010/bulgaria_2010_country_progress_report_en.pdf.
70. Vadhan N.P., Hart C.L., Haney M., van Gorp W.G., Foltin R.W. Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance. Drug Alcohol Depend. 2009, 102:95-101.
71. van Honk J., Hermans E.J., Putman P., Montagne B., Schutter D.J. Defective somatic markers in sub-clinical psychopathy. Neuroreport 2002, 13:1025-1027.
72. Vassileva J., Petkova P., Georgiev S., Martin E.M., Tersiyski R., Raycheva M., Velinov V., Marinov P. Impaired decision-making in psychopathic heroin addicts. Drug Alcohol Depend. 2007, 86:287-289.
73. Verdejo-Garcia A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 2008, 32:777-810.
74. Verdejo-Garcia A., Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007, 190:517-530.
75. Verdejo-Garcia A.J., Perales J.C., Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict. Behav. 2007, 32:950-966.
76. Vollm B., Richardson P., McKie S., Reniers R., Elliott R., Anderson I.M., Williams S., Dolan M., Deakin B. Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals. J. Psychiatr. Res. 2010, 44:123-131.
77. Widom C.S. A methodology for studying noninstitutionalized psychopaths. J. Consult. Clin. Psychol. 1977, 45:674-683.
78. Yang Y., Raine A., Lencz T., Bihrle S., LaCasse L., Colletti P. Volume reduction in prefrontal gray matter in unsuccessful criminal psychopaths. Biol. Psychiatry 2005, 57:1103-1108.